Skip to main content
Associated partners CA

Canadian Institutes of Health Research

CIHR

Programme phases

2

Funding participation

Joint calls funded by this organisation.

4

Funded projects

Projects linked to this funding organisation.

10
CHRYSALIS

Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian Cancer through multiOMICS analysis

JTC 2021
View project
DC2M-TAEC

Detection, Classification, Characterization and Treatment Monitoring of Tumors by Accessible Epigenetic Classification

JTC 2023
View project
EPI_T-ALL

Unveiling the Epigenetic Landscape and Therapeutic Implications of Epigenetic Modifiers in Human T-cell Leukemia Initiation and Progression

JTC 2023
View project
LipidMac

Exploiting lipid-laden macrophages to overcome resistance to cancer immunotherapy

JTC 2021
View project
MAGNOLIA

MAppinG adaptatioN Of tripLe negative breast cancer microenvironments to ImmunotherApy

JTC 2021
View project
METRICs

Metabolism/Metagenomics-based strategies for sensitization to Radio- and Immuno- therapy Combinations.

JTC 2024
View project
PREDICT-BC

Patient-derived models for the Research and Evaluation of Discovery and Innovation in Combination Therapies for Biliary Cancer

JTC 2024
View project
REACTION

Deciphering Epigenetic Biomarkers to Identify Preleukemic Carriers at Risk

JTC 2023
View project
SARAH

Search for combinational therapy to target clonal haematopoiesis in solid malignancies

JTC 2024
View project
SmartCAR-T

SmartCAR-T - Reprogramming of the tumor microenvironment with modular engineered CAR-T cells to augment the efficacy of immunotherapy

JTC 2021
View project